AI strategies often fail to get sustained funding because they lack detailed financial models beyond simple cost savings. A credible blueprint must quantify projected revenue uplift for each initiative, a step often skipped because strategists lack the deep pharma AI experience to make accurate forecasts.

Most AI ROI models are optimistic projections, not true business cases. They fail because their financial assumptions about user adoption, data availability, and decision speed don't account for the fragmented governance and misaligned incentives that are constraining the organization. The model assumes a reality that doesn't exist.

A CFO doesn't care that AI can summarize literature faster. They care that faster synthesis shortens publication times, accelerates HCP uptake, and impacts sales by a quantifiable amount. A credible financial case must map the entire chain of causality from an AI capability to a specific, revenue-driving business decision.

Founders are consistently and universally wrong about their financial projections, particularly cash runway. AI tools can provide an objective, data-driven forecast based on trailing growth, correcting for inherent founder optimism and preventing critical miscalculations.

AI requires significant upfront investment with uncertain returns, creating an "investment paradox" for CFOs. Traditional ROI models are insufficient. A new financial framework is needed that measures not just cost savings but also revenue acceleration, risk mitigation, and the strategic option value of competitive positioning.

To get CFO buy-in, don't just model the upside of AI investment. A more powerful approach is to include a baseline scenario showing the quantifiable business impact of delaying action. This frames the investment not just as an opportunity, but as a necessary defense against competitive disadvantage and market pressures like the patent cliff.

A Bain survey reveals a critical financial risk in enterprise AI adoption. Nearly half of companies are funding their next wave of AI investment based on assumed cost savings from previous projects. With actual savings falling far short of projections, this creates a 'circular bet with a structural leak' that threatens future AI budgets.

Advanced AI tools can model an organization's internal investment beliefs and processes. This allows investment committees to use the AI to "red team" proposals by prompting it to generate a memo with a negative stance or to re-evaluate a deal based on a new assumption, like a net-zero mandate.

Leaders often expect AI to produce a shiny, marketable feature. When AI’s value is 'invisible'—baked into workflows to improve efficiency—translate those gains into concrete financial outcomes like cost savings or accelerated revenue, rather than focusing on the process improvements themselves.